Medicare and Medicaid: COVID-19 Program Flexibilities and Considerations for Their Continuation, Statement of Jessica Farb, Director, Health Care Carolyn L. Yocom, Director, Health Care, Testimony Before the Committee on Finance, U.S. Senate [open pdf - 618KB]
From the Highlights: "Medicare and Medicaid--two federally financed health insurance programs-- spent over $1.5 trillion on health care services provided to about 140 million beneficiaries in 2020. Recognizing the critical role of these programs in providing health care services to millions of Americans, the federal government has provided for increased funding and program flexibilities, including waivers of certain federal requirements, in response to the COVID-19 [coronavirus disease 2019] pandemic. The CARES [Coronavirus Aid, Relief, and Economic Security] Act includes a provision for GAO [Government Accountability Office] to conduct monitoring and oversight of the federal government's response to the COVID-19 pandemic. In response, GAO has issued a series of government-wide reports from June 2020 through March 2021. GAO is continuing to monitor and report on these services. This testimony summarizes GAO's findings from these reports related to Medicare and Medicaid flexibilities during the COVID-19 pandemic, as well as preliminary observations from ongoing work related to telehealth waivers in both programs. Specifically, the statement focuses on what is known about the effects of these waivers and flexibilities on Medicare and Medicaid, and considerations regarding their ongoing use."
Government Accountability Office: http://www.gao.gov/